Best Practices starting a Biotech: Lessons learned from Industry Leaders
Precision Medicine Initiative at Columbia University was host to the inaugural Life Science Entrepreneurship seminar series. The series consisted of 4 classes, each centered around a case study exploring best practices among industry leaders.
The objective of the seminar series was to expose graduate students and young faculty from the life science disciplines to the entrepreneurial world. The hope was that the seminar series informed and inspired the participants to consider careers in biotechnology. The audience included graduate students, postdocs and young faculty from the life science disciplines and related faculties at the University.
George Yancopoulos, Leonard Schleifer
From Research to Clinic Target Patient
Value Proposition and Forecasting
Investors, Clinical Development and Regulatory Pathway
The Regeneron story tells the challenges and key decisions that lead to one of the most successful biotechnology companies.
This lecture in the Columbia Precision Medicine Initiative, Life Science Entrepreneurship seminar series, features a discussion with two of Regeneron’s leadership team: President and CSO George Yancopoulos, MD, PhD, and President and CEO of Regeneron, Leonard Schleifer, MD, PhD. The panel, moderated by the Director of the Columbia Precision Medicine Initiative Tom Maniatis, PhD, covers the life-cycle of an idea from basic research to a commercially viable product with a focus on Target Patient, Value Proposition and Forecasting; Attracting Investors; Clinical Development and Regulatory Pathways.